Pharmaceutical product
Latest Merck & Co., Inc. Patents:
- Assays for resistance to echinocandin-class drugs
- ASSAYS FOR RESISTANCE TO ECHINOCANDIN-CLASS DRUGS
- Assays for resistance to echinocandin-class drugs
- INTEGRIN TARGETING AGENTS AND IN-VIVO AND IN-VITRO IMAGING METHODS USING THE SAME
- Integrin targeting agents and in-vivo and in-vitro imaging methods using the same
Description
FIG. 1 is a perspective view of a pill or tablet and the like showing our new design;
FIG. 2 is a top plan view thereof, the bottom plan view is identical;
FIG. 3 is a side view thereof, the opposite side view is identical; and,
FIG. 4 is an end view thereof, the opposite end is identical.
Referenced Cited
Patent History
Patent number: D351464
Type: Grant
Filed: Sep 29, 1992
Date of Patent: Oct 11, 1994
Assignee: Merck & Co., Inc. (Rahway, NJ)
Inventors: Kenneth A. Kramer (Green Lane, PA), Ashok V. Katadare (Norristown, PA)
Primary Examiner: Wallace R. Burke
Assistant Examiner: M. H. Tung
Attorneys: Joanne M. Giesser, Melvin Winokur, Charles M. Caruso
Application Number: 0/2,317
Type: Grant
Filed: Sep 29, 1992
Date of Patent: Oct 11, 1994
Assignee: Merck & Co., Inc. (Rahway, NJ)
Inventors: Kenneth A. Kramer (Green Lane, PA), Ashok V. Katadare (Norristown, PA)
Primary Examiner: Wallace R. Burke
Assistant Examiner: M. H. Tung
Attorneys: Joanne M. Giesser, Melvin Winokur, Charles M. Caruso
Application Number: 0/2,317
Classifications
Current U.S. Class:
Pharmaceutical Product (D24/100)
